lipoxin a4 has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akdoğan Kayhan, M; Gül, M; Karaca, ZM; Kayhan, B; Kurtoğlu, EL; Yeşilada, E; Yılmaz, S | 1 |
| Arroyo, V; Clària, J; Ginès, P; Jiménez, W; Rivera, F; Rodés, J; Ros, J; Titos, E | 1 |
2 other study(ies) available for lipoxin a4 and Liver Cirrhosis
| Article | Year |
|---|---|
A bioactive product lipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes.
Topics: Activating Transcription Factor 2; Animals; Gene Expression Regulation; Hepatocytes; Lipoxins; Liver; Liver Cirrhosis; MAP Kinase Kinase 4; MAP Kinase Kinase 7; Mice; Models, Theoretical; Phytochemicals; Regeneration | 2019 |
Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites.
Topics: Angiotensin II; Arachidonate 15-Lipoxygenase; Arachidonate 5-Lipoxygenase; Ascites; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxins; Liver Cirrhosis; Neutrophils; RNA, Messenger | 1998 |